The Pennant Group, Inc. (PNTG)
USD 28.15
(-3.63%)
USD 28.15
(-3.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 61.9 Million USD | 14.43% |
| 2022 | 58.58 Million USD | 28.09% |
| 2021 | 45.73 Million USD | -16.67% |
| 2020 | 54.88 Million USD | 23.03% |
| 2019 | 44.61 Million USD | 5.13% |
| 2018 | 42.43 Million USD | 30.95% |
| 2017 | 32.4 Million USD | 14.58% |
| 2016 | 28.28 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 21.44 Million USD | 11.64% |
| 2024 Q1 | 19.2 Million USD | 10.46% |
| 2023 Q1 | 14.26 Million USD | -11.87% |
| 2023 FY | 67.03 Million USD | 14.43% |
| 2023 Q2 | 16.26 Million USD | 14.05% |
| 2023 Q3 | 17.8 Million USD | 9.42% |
| 2023 Q4 | 17.38 Million USD | -2.33% |
| 2022 Q4 | 16.18 Million USD | 13.36% |
| 2022 FY | 58.58 Million USD | 28.09% |
| 2022 Q3 | 14.27 Million USD | -1.67% |
| 2022 Q2 | 14.52 Million USD | 7.52% |
| 2022 Q1 | 13.5 Million USD | 65.27% |
| 2021 Q2 | 13.52 Million USD | 11.97% |
| 2021 Q1 | 12.07 Million USD | -19.12% |
| 2021 FY | 45.73 Million USD | -16.67% |
| 2021 Q3 | 11.96 Million USD | -11.49% |
| 2021 Q4 | 8.17 Million USD | -31.72% |
| 2020 Q2 | 14.81 Million USD | 23.93% |
| 2020 FY | 54.88 Million USD | 23.03% |
| 2020 Q4 | 14.93 Million USD | 13.19% |
| 2020 Q3 | 13.19 Million USD | -10.96% |
| 2020 Q1 | 11.95 Million USD | 8.7% |
| 2019 Q2 | 11.16 Million USD | 2.59% |
| 2019 FY | 44.61 Million USD | 5.13% |
| 2019 Q3 | 11.57 Million USD | 3.68% |
| 2019 Q1 | 10.88 Million USD | -0.08% |
| 2019 Q4 | 10.99 Million USD | -4.99% |
| 2018 Q2 | 17.92 Million USD | 0.17% |
| 2018 Q3 | 11.01 Million USD | -38.59% |
| 2018 FY | 42.43 Million USD | 30.95% |
| 2018 Q1 | 17.89 Million USD | 0.0% |
| 2018 Q4 | 10.89 Million USD | -1.09% |
| 2017 FY | 32.4 Million USD | 14.58% |
| 2016 FY | 28.28 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 90.931% |
| Addus HomeCare Corporation | 339.87 Million USD | 81.786% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | 49.218% |
| Amedisys, Inc. | 457.07 Million USD | 86.456% |
| American Oncology Network, Inc. | 66.05 Million USD | 6.284% |
| Astrana Health, Inc. | 214.95 Million USD | 71.201% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 89.603% |
| IMAC Holdings, Inc. | 3.84 Million USD | -1508.525% |
| biote Corp. | 127.48 Million USD | 51.44% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -170.316% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 85.672% |
| COMPASS Pathways plc | -242.93 Thousand USD | 25582.222% |
| DocGo Inc. | 178.95 Million USD | 65.406% |
| The Ensign Group, Inc. | 590.75 Million USD | 89.521% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 75.38% |
| InnovAge Holding Corp. | 132.06 Million USD | 53.124% |
| Assure Holdings Corp. | -2.19 Million USD | 2921.604% |
| The Joint Corp. | 107.14 Million USD | 42.225% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 79.508% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 5876.726% |
| ModivCare Inc. | 446.95 Million USD | 86.149% |
| NewGenIvf Group Limited | 1.68 Million USD | -3580.97% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -1149.941% |
| Option Care Health, Inc. | 981.22 Million USD | 93.691% |
| P3 Health Partners Inc. | 31.63 Million USD | -95.688% |
| P3 Health Partners Inc. | 31.63 Million USD | -95.688% |
| Surgery Partners, Inc. | 529.4 Million USD | 88.306% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -4284.588% |
| Talkspace, Inc. | 74.38 Million USD | 16.771% |
| Talkspace, Inc. | 74.38 Million USD | 16.771% |
| The Oncology Institute, Inc. | 59.57 Million USD | -3.916% |
| The Oncology Institute, Inc. | 59.57 Million USD | -3.916% |